1. Executive Summary 2. Japan In–Vitro Diagnostics (IVD) Market and Market Share Analysis – Forecast to 2030 2.1 Japan IVD Market and Forecast (2008 – 2030) 2.2 By Segment – Japan IVD Market Share and Forecast (2008 – 2030) 2.3 By Company – Japan IVD Share and Forecast (2015 – 2030) 3. Japan IVD – Segments Wise Market and Forecast (2008 – 2030) 3.1 Urine & Feces Market and Forecast 3.2 Hematology Market and Forecast 3.3 Clinical Chemistry Market and Forecast 3.4 SMBG Market and Forecast 3.5 Tumor Marker Market and Forecast 3.6 Immunoassay Market and Forecast 3.7 Infectious Disease Market and Forecast 3.8 Microbiology Market and Forecast 3.9 Pathology Market and Forecast 3.10 Genetic Testing Market and Forecast 3.11 Others Market and Forecast 4. Japan IVD Market – Company Analysis (2014 – 2030) 4.1 Roche Diagnostics 4.1.1 Company Overview 4.1.2 Roche Diagnostics – Japan IVD Sales and Forecast 4.1.3 Recent Developments 4.2 Abbott Laboratories 4.2.1 Company Overview 4.2.2 Abbott Laboratories – Japan IVD Sales and Forecast 4.2.3 Recent Developments 4.3 Danaher Corporation 4.3.1 Company Overview 4.3.2 Danaher Corporation – Japan IVD Sales and Forecast 4.3.3 Recent Developments 4.4 bioMérieux S.A. 4.4.1 Company Overview 4.4.2 Biomerieux – Japan IVD Sales and Forecast 4.4.3 Recent Developments 4.5 Sysmex Corporation 4.5.1 Company Overview 4.5.2 Sysmex Corporation – Japan IVD Sales and Forecast 4.5.3 Recent Developments 4.6 Bio–Rad Laboratories, Inc. 4.6.1 Company Overview 4.6.2 Bio–Rad Laboratories, Inc – Japan IVD Sales and Forecast 4.6.3 Recent Developments 4.7 Becton Dickinson and Company 4.7.1 Company Overview 4.7.2 Becton Dickinson and Company – Japan IVD Sales and Forecast 4.7.3 Recent Developments 4.8 Thermo Fisher Scientific Inc. 4.8.1 Company Overview 4.8.2 Thermo Fisher Scientific Inc. – Japan IVD Sales and Forecast 4.8.3 Recent Developments 4.9 Others – Japan IVD Sales and Forecast 5. In-Vitro Diagnostics (IVD) Market – Major Deals 6. In-Vitro Diagnostics (IVD) Market - Recent Developments 7. Japan In–Vitro Diagnostics – Market Dynamics 7.1 Japan IVD Market – Driving Factors 7.2 Japan IVD Market – Challenges

List of Figures: Figure 2-1: Japan – IVD Market (Million US$), 2008 – 2023 Figure 2-2: Japan – Forecast for IVD Market (Million US$), 2024 – 2030 Figure 3-1: Japan – Urine & Feces Market (Million US$), 2008 – 2023 Figure 3-2: Japan – Forecast for Urine & Feces Market (Million US$), 2024 – 2030 Figure 3-3: Japan – Hematology Market (Million US$), 2008 – 2023 Figure 3-4: Japan – Forecast for Hematology Market (Million US$), 2024 – 2030 Figure 3-5: Japan – Clinical Chemistry Market (Million US$), 2008 – 2023 Figure 3-6: Japan – Forecast for Clinical Chemistry Market (Million US$), 2024 – 2030 Figure 3-7: Japan – SMBG Market (Million US$), 2008 – 2023 Figure 3-8: Japan – Forecast for SMBG Market (Million US$), 2024 – 2030 Figure 3-9: Japan – Tumor Marker Market (Million US$), 2008 – 2023 Figure 3-10: Japan – Forecast for Tumor Marker Market (Million US$), 2024 – 2030 Figure 3-11: Japan – Immunoassay Market (Million US$), 2008 – 2023 Figure 3-12: Japan – Forecast for Immunoassay Market (Million US$), 2024 – 2030 Figure 3-13: Japan – Infectious Disease Market (Million US$), 2008 – 2023 Figure 3-14: Japan – Forecast for Infectious disease Market (Million US$), 2024 – 2030 Figure 3-15: Japan – Microbiology Market (Million US$), 2008 – 2023 Figure 3-16: Japan – Forecast for Microbiology Market (Million US$), 2024 – 2030 Figure 3-17: Japan – Pathology Market (Million US$), 2008 – 2023 Figure 3-18: Japan – Forecast for Pathology Market (Million US$), 2024 – 2030 Figure 3-19: Japan – Genetic Testing Market (Million US$), 2008 – 2023 Figure 3-20: Japan – Forecast for Genetic Testing Market (Million US$), 2024 – 2030 Figure 3-21: Japan – Others Market (Million US$), 2008 – 2023 Figure 3-22: Japan – Forecast for Others Market (Million US$), 2024 – 2030 Figure 4-1: Roche Diagnostics – Japan IVD Sales (Million US$), 2012 – 2023 Figure 4-2: Roche Diagnostics – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-3: Abbott Laboratories – Japan IVD Sales (Million US$), 2012 – 2023 Figure 4-4: Abbott Laboratories – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-5: Danaher Corporation – Japan IVD Sales (Million US$), 2014 – 2023 Figure 4-6: Danaher Corporation – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-7: biomerieux – Japan IVD Sales (Million US$), 2015 – 2023 Figure 4-8: Biomerieux – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-9: Sysmex Corporation – Japan IVD Sales (Million US$), 2010 – 2023 Figure 4-10: Sysmex Corporation – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-11: Bio–Rad Laboratories, Inc – Japan IVD Sales (Million US$), 2014 – 2023 Figure 4-12: Bio–Rad Laboratories, Inc – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-13: Becton Dickinson and Company – Japan IVD Sales (Million US$), 2014 – 2023 Figure 4-14: Becton Dickinson and Company – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-15: Thermo Fisher Scientific Inc. – Japan IVD Sales (Million US$), 2014 – 2023 Figure 4-16: Thermo Fisher Scientific Inc. – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 Figure 4-17: Others – Japan IVD Sales (Million US$), 2015 – 2023 Figure 4-18: Others – Forecast for Japan IVD Sales (Million US$), 2024 – 2030 List of Tables: Table 2-1: By Segment – Japan IVD Market Share (Percent), 2008 – 2023 Table 2-2: By Segment – Forecast for Japan IVD Market Share (Percent), 2024 – 2030 Table 2-3: By Company – Japan IVD Market Share (Percent), 2015 – 2023 Table 2-4: By Company – Forecast for Japan IVD Market Share (Percent), 2024 – 2030

1. Roche Diagnostics 2. Abbott Laboratories 3. Danaher Corporation 4. bioMérieux S.A. 5. Sysmex Corporation 6. Bio-Rad Laboratories, Inc. 7. Becton Dickinson Company 8. Thermo Fisher Scientific Inc.